Xeriant, Inc.

XERI · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Revenue$0$67$0$0
% Growth-100%
Cost of Goods Sold$0$33$5$14
Gross Profit$0$33-$5-$14
% Margin50%
R&D Expenses$54$12$30$0
G&A Expenses$109$49$424$322
SG&A Expenses$109$200$429$336
Sales & Mktg Exp.$0$134$5$13
Other Operating Expenses$141$0$0$0
Operating Expenses$304$212$459$336
Operating Income-$304-$212-$459-$336
% Margin-317.8%
Other Income/Exp. Net$2,655-$115-$71-$82
Pre-Tax Income$2,351-$327-$530-$417
Tax Expense$125$0$0$0
Net Income$2,226-$327-$528-$410
% Margin-489.9%
EPS0.003-0.001-0.001-0.001
% Growth720%37.5%-14.3%
EPS Diluted0.001-0.001-0.001-0.001
Weighted Avg Shares Out716,716620,875654,797596,196
Weighted Avg Shares Out Dil2,367,087620,875654,797596,196
Supplemental Information
Interest Income$0$0$0$0
Interest Expense-$45$50$71$77
Depreciation & Amortization$0$0$5$14
EBITDA-$304-$212-$454-$326
% Margin-317.1%
Xeriant, Inc. (XERI) Financial Statements & Key Stats | AlphaPilot